Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’’s disease in children: REACH open-label extension

By Hyams Jeffrey   Walters Thomas D.   Crandall Wallace   Kugathasan Subra   Griffiths Anne   Blank Marion   Johanns Jewel   Lang Yinghua   Markowitz James   Cohen Stanley   Winter Harland S.   Veereman-Wauters Gigi   Ferry George   Baldassano Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 651-662

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4‐week, open‐label clinical study

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCH Phase 3 Open‐Label Study

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 248-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study*

By Feuerhake Cord   Buchholz Patricia   Kimmich Friedemann  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1037-1043

Informa Healthcare

Access to resources Recommend Favorite